Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)

Clinical trial NCT05762211 · RECRUITING

Trial details

NCT number: NCT05762211
Sponsor: MaaT Pharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Transplant Complication

Start date: 2023-10-31
Primary completion: 2026-10-31
Enrollment: 387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.